Conference Coverage
Conference Coverage
‘Modest’ benefit for post-MI T2D glucose monitoring
Equivocal results were seen with regard to the best method to monitor blood glucose after myocardial infarction.
Conference Coverage
VOYAGER PAD: Paclitaxel-coated devices don’t increase mortality
“I think this study is a game changer. And I think the paclitaxel game is over.” – Dr. Frank Veith
Conference Coverage
Link between vitamin D and ICU outcomes unclear
When patients are admitted to the ICU, some biomarkers in the body are too high and others are too low. Vitamin D is often too low.
Conference Coverage
National lung cancer screening guidelines may miss younger African American individuals at high risk
Retrospective analysis finds many lung cancer patients would not have counted as eligible for low-dose CT under guidelines that are being...
Conference Coverage
Intravascular lithotripsy hailed as ‘game changer’ for coronary calcification
Positive results reported from the U.S. pivotal Disrupt CAD III study sets stage for regulatory approval.
Conference Coverage
Diabetic neuropathic pain linked to brain bioenergic anomalies
Changes in mitochondrial activity in pain-processing areas of the brain may help explain why some persons with diabetes experience painful...
Conference Coverage
Fauci: Cautious optimism for COVID-19 vaccine by end of 2020
Top health official is “cautiously optimistic” for vaccine distribution before end of year, pending favorable safety and efficacy data.
Conference Coverage
NACMI: Clear benefit with PCI in STEMI COVID-19 patients
Angiography fell off but door-to-balloon times haven’t suffered, even with the pandemic, according to initial results from the North American...
Conference Coverage
Telemedicine feasible and reliable in Parkinson’s trial
The findings have particular relevance to the ability to conduct a variety of clinical trials in the face of COVID-19 and the need to limit in-...
Conference Coverage
COVID-19 vaccine hesitancy ‘somewhat understandable,’ expert says
Dr. Offit predicts a vaccine may be able to be 75%-80% effective at preventing mild to moderate disease.